Cadila

• 

  Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets

  Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of

• 

  Zydus Cadila Begins Supply Of Covid Vaccine ZyCoV-D To Government

  Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art.

• 

  Zydus Cadila Gets US Approval To Market Generic Schizophrenia Drug

  Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market generic drug Cariprazine capsules, which are used in the treatment of schizophrenia.

• 

  Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially

  Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.

• 

  Stocks To Watch: Coal India, Future Retail, IOB, Cadila Healthcare

  The domestic stock markets are expected to trade cautiously on Thursday, taking cues from the global markets.

• 

  South Korea's Enzychem To Make Cadila's COVID-19 Shot

  South Korea's Enzychem Lifesciences would make at least 80 million doses of India's homegrown DNA COVID-19 vaccine from Cadila Healthcare, the Indian drugmaker said on Wednesday.

• 

  Zydus Cadila Gets Final Approval From US FDA For Pre-Surgery Injection

  India-based pharma giant, Zydus Cadila received final approval from US Food and Drug Administration (FDA) for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.

• 

  Stocks To Watch: Reliance Industries, Cadila Healthcare, Britannia

  Stocks To Watch Today, November 9: Reliance Industries, Cadila Healthcare, Britannia are in focus for today's trading session

• 

  India To Buy 1 Crore Zydus Cadila 'Needle-Free' Covid Shots At Rs 265 Each

  The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20.

• 

  Zydus Cadila Agrees To Reduce Covid Vaccine Price To Rs 265 Per Dose: Report

  Zydus Cadila's ZyCov-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above

• 

  60 Lakh Doses Of Zydus Cadila's Vaccine Ready After Production In October: Report

  As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.

• 

  Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre

  The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.

• 

  This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'

  Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.

• 

  Talks On To Make Covid DNA Vaccine Part Of Inoculation Drive: Centre

  Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people and although the price is a "clear issue", a decision will be taken soon to make it a part of the country's vaccination programme, the government said on Thursday.

• 

  Stocks To Watch: Adani Ports, HCL Tech, Cadila Healthcare

  Adani Ports has received go-ahead from the Competition Commission of India to acquire 10.40 per cent shareholding of Gangavaram Port